The Claim
In patients with neuropsychiatric disorders, elevated circulating reverse triiodothyronine (rT3) levels and reduced T3/rT3 ratios are associated with increased symptom severity and reduced responsiveness to standard psychiatric treatments, suggesting that thyroid hormone metabolic disruption may directly influence clinical presentation and therapeutic outcomes.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For people with mental health conditions, having higher levels of a specific thyroid hormone byproduct and a lower ratio of active thyroid hormones seems to go hand-in-hand with worse symptoms and less response to usual psychiatric medications. This suggests that how the body processes thyroid hormones might play a direct role in how severe the condition is and how well treatments work.
See the scientific wording
In individuals with neuropsychiatric disorders, higher circulating reverse triiodothyronine (rT3) levels and lower T3/rT3 ratios are associated with greater symptom severity and increased resistance to standard psychiatric treatments. This dose-response-like relationship suggests that the degree of thyroid hormone metabolic disruption may directly influence clinical presentation and therapeutic outcomes.
What the research says
1 studyStudy: The Influence of Reverse Triiodothyronine on Neuropsychiatric Disorders: A Narrative Review.
The study confirms that high levels of a specific thyroid hormone byproduct (rT3) and a low ratio of active to inactive thyroid hormones are linked to worse symptoms and harder-to-treat mental health conditions.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.